Filana Therapeutics
FLNA
73 hedge funds and large institutions have $104M invested in Filana Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 19 closing their positions.
11,150% more call options, than puts
Call options by funds: $225K | Put options by funds: $2K
50% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 20
16% less funds holding
Funds holding: 87 → 73 (-14)
33% less capital invested
Capital invested by funds: $154M → $104M (-$50.2M)
74% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 19
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$2.5M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.3M |
| 3 |
MSP
Madison Street Partners
Denver,
Colorado
|
+$731K |
| 4 |
JIR
James Investment Research
Alpha,
Ohio
|
+$723K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$537K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.81M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.68M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$1.6M |
| 4 |
Jane Street
New York
|
-$615K |
| 5 |
Two Sigma Investments
New York
|
-$582K |
FLNA Hedge Fund Activity: Q3 2014 in Review
73 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2014, worth a combined $104M — down 33% from $154M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of FLNA and 5 opened new positions — a net loss of 14 holders — while 20 trimmed existing stakes and 30 added.
The largest buyer was First Eagle Investment Management, adding an estimated $2.5M. The largest seller was Pictet Asset Management (UK), exiting entirely with an estimated $1.81M sold.
- 73 institutional investors held Filana Therapeutics (FLNA) as of Q3 2014, down from 87 in Q2 2014.
- Funds reported $104M of Filana Therapeutics stock for Q3 2014, down 33% quarter-over-quarter.
- 5 funds opened new Filana Therapeutics positions in Q3 2014 and 19 closed out, a net change of -14 holders.
- The largest Filana Therapeutics buyer in Q3 2014 was First Eagle Investment Management, an estimated $2.5M added.
- The largest Filana Therapeutics seller in Q3 2014 was Pictet Asset Management (UK), an estimated $1.81M sold.
Based on aggregated 13F filings for Q3 2014.